Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
251.41
+0.62 (0.25%)
At close: Nov 18, 2026, 4:00 PM EST
251.60
+0.19 (0.08%)
After-hours: Nov 18, 2026, 5:12 PM EST
Biogen (BIIB) Product Revenue by Segment
| Date | Multiple Sclerosis | Rare Disease | Specialized Immunology | Biosimilars | Other | Alzheimers Disease |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | 3.76B | 2.35B | 370.60M | 670.70M | 276.30M | - |
| Jun 30, 2026 | 3.90B | 2.21B | 127.80M | 701.60M | 247.20M | - |
| Mar 31, 2026 | 4.04B | 2.15B | - | 730.50M | 223.20M | - |
| Dec 31, 2025 | 4.04B | 2.15B | - | 729.10M | 197.20M | - |
| Sep 30, 2025 | 4.19B | 2.17B | - | 761.30M | 157.10M | - |
| Jun 30, 2025 | 4.18B | 2.14B | - | 761.10M | 125.90M | - |
| Mar 31, 2025 | 4.23B | 2.13B | - | 777.50M | 96.70M | - |
| Dec 31, 2024 | 4.35B | 1.99B | - | 793.60M | 82.50M | - |
| Sep 30, 2024 | 4.45B | 1.87B | - | 779.80M | 58.30M | - |
| Jun 30, 2024 | 4.55B | 1.82B | - | 777.50M | 37.90M | - |
| Mar 31, 2024 | 4.61B | 1.72B | - | 774.50M | 24.60M | - |
| Dec 31, 2023 | 4.66B | 1.74B | - | 770.00M | 11.80M | - |
| Sep 30, 2023 | 4.76B | 1.79B | - | 756.60M | 15.30M | - |
| Jun 30, 2023 | 4.94B | 1.77B | - | 749.90M | 14.70M | - |
| Mar 31, 2023 | 5.16B | 1.76B | - | 749.20M | 13.20M | - |
| Dec 31, 2022 | 5.43B | 1.79B | - | 751.10M | 13.00M | 2.80M |
| Sep 30, 2022 | 5.69B | 1.78B | - | 797.20M | 10.70M | 5.50M |
| Jun 30, 2022 | 5.91B | 1.79B | - | 812.40M | 10.10M | 5.80M |
| Mar 31, 2022 | 6.01B | 1.86B | - | 820.40M | 10.40M | 5.80M |
| Dec 31, 2021 | 6.10B | 1.91B | - | 831.20M | 11.00M | 3.00M |